Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-735-9 | CAS number: 70-47-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
There are no experimental toxicokinetic data available for L-asparagine, thus, the toxicokinetic behaviour of the test item was evaluated according to ECHA endpoint specific guidance Chapter 7c based on its physico-chemical properties. A detailed description is given below.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
- Absorption rate - oral (%):
- 50
- Absorption rate - dermal (%):
- 50
- Absorption rate - inhalation (%):
- 100
Additional information
Data from in vitro or in vivo studies, which were designed to identify the toxicokinetic properties of L-asparagine, are not available. But there are published results substantiating the assumed toxicokinetic behaviour which is in line with the physico-chemical properties of L-asparagine
Parameter |
Value used for CSR |
Molecular Weight |
132.12 g/mol |
Melting Point |
234-235°C decomposition |
Boiling Point |
n.a. (decomposition) |
Density |
1.543 g/cm3 |
Vapour Pressure |
2.26 E-005 Pa |
Partition coefficient n-octanol/water (log Kow) |
-4.99 |
Water solubility |
22.1 g/L |
CMC |
0.009 g/L (at 25°C) |
pKa1 |
2.02 |
pKa2 |
8.80 |
Particle size |
awaiting granulometry tests results |
Oral absorption
L-asparagine has a molecular weight of less than 500 g/mol and a log Kow of -4.99 which is in general a prerequisite for absorption. Due to its structure L-asparagine possesses two pKa values therefore it will be present in its unionized form in stomach (pH 2) as well as in the small intestine (pH 8) which is also favourable for absorption. L-asparagine is a ubiquitous occurring component in proteins and polypeptides. Furthermore, L-asparagine is a substrate for the intermediary metabolism. It is either formed by L-aspartic acid and glutamine or hydrolysed to L-aspartic acid but mainly L-asparagine is incorporated into proteins (Krotkov et al. 1953, O´Connor et al. 1994). It was reported that only 14 % of ingested L-asparagine is exhaled as CO2and that about 45% of it is recovered in the remaining carcass. The overall recovery from the main tissues in rats was nearly 100%, for this reason it can be considered that the absorption rate for L-asparagine is 50 % for both animals and humans with respect to ECHA endpoint specific guidance Chapter 7c.
Respiratory absorption
L-asparagine is a solid at room temperature and decomposes at 235°C together with a low vapor pressure of 2.26 E-005 Pa substance evaporation and uptake by inhalation is unlikely. However, the uptake after direct inhalation of substance dust particles and aerosols is possible because L-asparagine is marketed and used in a granular form,but considered very unlikely because the median particle size was determined to be D50 = 251.2 µm which is above the critical size for particles to be inhaled (i.e. 100 µm). Nevertheless, after uptake L-asparagine it will be readily absorbed due to its physicochemical properties, i.e. its high water solubility (22.1 g/L) or its low log Kow and is therefore unlikely to be coughed or sneezed out of the body. It will be taken up and possibly immediately be metabolised or incorporated into proteins and therefore be indistinguishable from asparagine taken up from other sources (i.e. diet). A deposition into lymphoid tissues is also rather unlikely.
Because L-asparagine is produced and marketed in granular form accidental exposure to dusts cannot be excluded. Thus, for precautionary reasons the estimated absorption of L-asparagine via the respiratory tract is 100%.
Dermal absorption
Due to its low molecular weight, its low log Kow and its high water solubility, L-asparagine may be dermally absorbed. Based on the pKa values of which one is 2.02 and the other is 8.80 L-asparagine is supposed to be partially ionized, but due to its small size (MW 132.12 g/mol) it is presumably absorbed. However, since L-asparagine is handled in its solid form, it is not expected to be dermally absorbed. Thus, because uptake of L-asparagine by dermal route is not expected but can also not be excluded and because dermal absorption is not expected to exceed oral uptake a value of 50% absorption after dermal exposure should be assumed. However, lower values for dermal absorption cannot be considered due to lack of data.
Distribution
As a small molecule a wide distribution can be expected. It was reported that the main occurrence of L-asparagine was detected in the whole carcass, whereas only 14.3 % were recovered in the gastro-intestinal tract and 7% of dietary administered L-asparagine was found in the liver (Breuer et al. 1966). The amount of respired L-asparagine was measured in another study but with remarkable varying results, between 14 and 36% of i.p. or s.c administered L-asparagine was respired as CO2(Krotkov et al. 1953). However, as demonstrated by the studies mentioned above, L-asparagine is mainly incorporated into proteins, i.e. metabolised in protein biosynthesis.
Metabolism
As a ubiquitous occurring molecule, L-asparagine in known to be readily metabolised by the intermediary metabolism. As mentioned before, it is a substrate for the synthesis of L-aspartic acid and therefore participates as a precursor in the generation of neurotransmitter (i.e. glutamate and aspartate. Furthermore, once aspartic acid is synthesised, it plays a key role in the urea cycle and is involved in transamination reactions e.g. with oxaloacetate, thereby acting as carbon source to form ATP (see also general biochemistry textbooks). The metabolism of L-asparagine is not restricted to mammalian species, also algae and bacteria are capable of using asparagine as a carbon source for energy supply (Oda et al. 1982, Alpert et al. 2009). Furthermore, it was shown that L-asparagine administered in a rat model of sepsis was able to improve muscle wasting and reduce weight loss naturally occurring with the condition of sepsis (Breuille et al. 2006). In another study it was reported that endotoxin administration inhibited gluconeogenesis rising from L-asparagine as a source (Perchellet et al. 1983). The results presented in this study indicate that L-asparagine plays a pivotal role in intermediary metabolism and its inhibition may be deleterious.
Elimination
The major routes of excretion for substances from the systemic circulation are the urine and/or the faeces. Excretion by exhalation does not seem to be relevant as demonstrated by Krotkov et al.(1953).
As depicted above, L-asparagine is metabolised either by forming L-aspartic acid or by entering the tricarboxylic acid cycle in order to provide reduction equivalents for energy supply. The third elimination route is the partition in protein synthesis. Thus, asparagine is rather incorporated into proteins than renally or biliary excreted.
Bioaccumulation
Based on the log Kow of -4.99 the substance is unlikely to accumulate with the repeated intermittent exposure patterns normally encountered in the workplace.
References
Krotkov, G., et al. "Utilization of asparagine by rats."Archives of biochemistry and biophysics42.2 (1953): 471-472.
M O'Connor, Clare. "Analysis of aspartic acid and asparagine metabolism in Xenopus laevis oocytes using a simple and sensitive HPLC method."Molecular reproduction and development39.4 (1994): 392-396.
Breuer Jr, L. H., et al. "Dietary requirement for asparagine and its metabolism in rats."Journal of Nutrition88 (1966): 143-150.
Breuillé, Denis, et al. "Beneficial effect of amino acid supplementation, especially cysteine, on body nitrogen economy in septic rats."Clinical Nutrition25.4 (2006): 634-642.
Oda, Yuji, Yoshihisa Nakano, and Shozaburo Kitaoka. "Utilization and toxicity of exogenous amino acids in Euglena gracilis."Microbiology128.4 (1982): 853-858.
Alpert, Carl, et al. "Adaptation of protein expression by Escherichia coli in the gastrointestinal tract of gnotobiotic mice."Environmental microbiology11.4 (2009): 751-761.
Perchellet, Jean-Pierre, Elizabeth A. Conrad, and R. K. Boutwell. "Effects of amino acid treatments on 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase activity in mouse epidermis in vivo and in vitro."Journal of investigative dermatology81.6 (1983): 560-566.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.